A detailed history of Fjarde Ap Fonden transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Fjarde Ap Fonden holds 54,947 shares of JAZZ stock, worth $6.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
54,947
Previous 40,247 36.52%
Holding current value
$6.07 Million
Previous $4.95 Million 33.68%
% of portfolio
0.07%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$115.19 - $132.77 $1.69 Million - $1.95 Million
14,700 Added 36.52%
54,947 $6.62 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $525,596 - $625,600
4,600 Added 12.9%
40,247 $4.95 Million
Q3 2023

Oct 23, 2023

BUY
$122.0 - $145.31 $256,200 - $305,151
2,100 Added 6.26%
35,647 $4.61 Million
Q2 2023

Aug 02, 2023

SELL
$122.5 - $147.16 $845,250 - $1.02 Million
-6,900 Reduced 17.06%
33,547 $4.16 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $710,094 - $850,491
5,300 Added 15.08%
40,447 $5.92 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $700,488 - $863,190
5,400 Added 18.15%
35,147 $5.6 Million
Q2 2022

Aug 11, 2022

BUY
$141.59 - $168.66 $283,180 - $337,320
2,000 Added 7.21%
29,747 $4.64 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $648,199 - $803,500
-5,000 Reduced 15.27%
27,747 $4.32 Million
Q4 2021

Feb 15, 2022

SELL
$119.87 - $145.67 $503,454 - $611,814
-4,200 Reduced 11.37%
32,747 $4.17 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $488,831 - $702,202
3,800 Added 11.46%
36,947 $4.81 Million
Q2 2021

Aug 12, 2021

BUY
$160.2 - $186.42 $528,660 - $615,186
3,300 Added 11.06%
33,147 $5.89 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $991,254 - $1.15 Million
6,600 Added 28.39%
29,847 $4.91 Million
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $211,065 - $247,575
1,500 Added 6.9%
23,247 $3.84 Million
Q3 2020

Nov 13, 2020

BUY
$105.46 - $144.13 $263,650 - $360,325
2,500 Added 12.99%
21,747 $3.1 Million
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $9,568 - $12,188
100 Added 0.52%
19,247 $2.12 Million
Q1 2020

May 11, 2020

BUY
$87.74 - $152.74 $526,440 - $916,440
6,000 Added 45.64%
19,147 $1.91 Million
Q4 2019

Feb 10, 2020

BUY
$117.65 - $153.73 $929,435 - $1.21 Million
7,900 Added 150.56%
13,147 $1.96 Million
Q3 2019

Oct 31, 2019

SELL
$125.18 - $143.24 $103,649 - $118,602
-828 Reduced 13.63%
5,247 $672,000
Q2 2019

Jul 17, 2019

SELL
$125.55 - $144.48 $1.02 Million - $1.17 Million
-8,116 Reduced 57.19%
6,075 $866,000
Q1 2019

Apr 29, 2019

SELL
$121.81 - $142.95 $154,942 - $181,832
-1,272 Reduced 8.23%
14,191 $2.03 Million
Q4 2018

Jan 31, 2019

SELL
$115.94 - $166.74 $452,166 - $650,286
-3,900 Reduced 20.14%
15,463 $1.92 Million
Q3 2018

Nov 09, 2018

SELL
$161.01 - $180.57 $131,706 - $147,706
-818 Reduced 4.05%
19,363 $3.26 Million
Q2 2018

Jul 12, 2018

SELL
$146.33 - $183.18 $27,363 - $34,254
-187 Reduced 0.92%
20,181 $3.48 Million
Q1 2018

May 07, 2018

BUY
$135.59 - $157.16 $40,677 - $47,148
300 Added 1.49%
20,368 $3.08 Million
Q4 2017

Feb 12, 2018

BUY
$131.06 - $150.39 $314,412 - $360,785
2,399 Added 13.58%
20,068 $2.7 Million
Q3 2017

Nov 07, 2017

BUY
$142.62 - $155.6 $28,524 - $31,120
200 Added 1.14%
17,669 $2.58 Million
Q2 2017

Aug 08, 2017

BUY
N/A
17,469
17,469 $2.72 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.92B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.